Hem › Major depression › Maryland
Kliniska studier för Major depression i Maryland
21 studier för Major depression söker deltagare vid platser i Maryland.
Städer i Maryland
Officiell studietext (engelska)
NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder
- National Institutes of Health Clinical Center, Bethesda
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 8 till 70 · Alla kön · Uppdaterad 2 okt. 2026 · NCT05669703Natural History of Depression, Bipolar Disorder and Suicide Risk
- National Institutes of Health Clinical Center, Bethesda
RekryterarObservationsstudie
Ålder 18 till 120 · Alla kön · Uppdaterad 1 okt. 2026 · NCT06462196A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Pharmasite Research, Inc., Baltimore
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 1 okt. 2026 · NCT07775300A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Pharmasite Research, Inc., Baltimore
RekryterarFas 3
Ålder 18 till 74 · Alla kön · Uppdaterad 1 okt. 2026 · NCT07573176Characterization and Treatment of Adolescent Depression
- National Institutes of Health Clinical Center, Bethesda
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 11 till 25 · Alla kön · Uppdaterad 28 sep. 2026 · NCT03388606A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Delricht Research - Rockville, Rockville
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07621237A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- Johns Hopkins University, Baltimore
RekryterarFas 3
Ålder 12 till 17 · Alla kön · Uppdaterad 25 sep. 2026 · NCT07227454A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Sunstone Medical, PC, Rockville
RekryterarFas 3
Ålder 18 till 85 · Alla kön · Uppdaterad 25 sep. 2026 · NCT06793397Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
- National Institutes of Health Clinical Center, Bethesda
RekryterarFas 1Friska volontärer välkomna
Ålder 18 till 65 · Alla kön · Uppdaterad 22 sep. 2026 · NCT03065335Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders
- National Institutes of Health Clinical Center, Bethesda
- University of Maryland, College Park, College Park
RekryterarFas 2Friska volontärer välkomna
Ålder 8 till 65 · Alla kön · Uppdaterad 22 sep. 2026 · NCT00018057Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression
- National Institutes of Health Clinical Center, Bethesda
RekryterarFas 2
Ålder 18 till 70 · Alla kön · Uppdaterad 14 sep. 2026 · NCT06511908Defining Neurobiological Links Between Substance Use and Mental Illness
- National Institute on Drug Abuse, Baltimore
RekryterarFriska volontärer välkomna
Ålder 18 till 60 · Alla kön · Uppdaterad 11 sep. 2026 · NCT05538910Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression
- National Institutes of Health Clinical Center, Bethesda
RekryterarFas 1
Ålder 18 till 70 · Alla kön · Uppdaterad 10 sep. 2026 · NCT03973268Neurobiology of Suicide
- National Institutes of Health Clinical Center, Bethesda
RekryterarFas 2Friska volontärer välkomna
Ålder 18 till 70 · Alla kön · Uppdaterad 9 sep. 2026 · NCT02543983A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Pharmasite Research Inc., Baltimore
RekryterarFas 3
Ålder 18 till 74 · Alla kön · Uppdaterad 8 sep. 2026 · NCT07076407A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Gaithersburg
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 26 aug. 2026 · NCT07300969A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Pharmasite Research, Inc., Baltimore
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 6 aug. 2026 · NCT07412756A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Continental Clinical Solutions, Towson
RekryterarFas 2
Ålder 18 till 64 · Alla kön · Uppdaterad 27 juli 2026 · NCT07115329Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Gaithersburg
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 24 juli 2026 · NCT06966401Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Pikesville
RekryterarFas 3
Ålder 18 till 65 · Alla kön · Uppdaterad 24 juli 2026 · NCT07484217A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Sheppard Pratt, Baltimore
- Sunstone Medical, PC, Rockville
RekryterarFas 2
Ålder 18 till 65 · Alla kön · Uppdaterad 11 maj 2026 · NCT06524830Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.